BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23575571)

  • 1. Treating cryptococcal meningitis in people with HIV.
    BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
    [No Abstract]   [Full Text] [Related]  

  • 2. Ending deaths from HIV-related cryptococcal meningitis by 2030.
    Shroufi A; Chiller T; Jordan A; Denning DW; Harrison TS; Govender NP; Loyse A; Baptiste S; Rajasingham R; Boulware DR; Ribeiro I; Jarvis JN; Van Cutsem G
    Lancet Infect Dis; 2021 Jan; 21(1):16-18. PubMed ID: 33271065
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
    N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in managing HIV-associated cryptococcal meningitis.
    Boyer-Chammard T; Temfack E; Alanio A; Jarvis JN; Harrison TS; Lortholary O
    F1000Res; 2019; 8():. PubMed ID: 31275560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Lofgren S; Abassi M; Rhein J; Boulware DR
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
    Jackson AT; Nussbaum JC; Phulusa J; Namarika D; Chikasema M; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; van der Horst C; Harrison TS
    AIDS; 2012 Jul; 26(11):1363-70. PubMed ID: 22526517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cryptococcal meningitis in resource limited settings.
    Sloan DJ; Dedicoat MJ; Lalloo DG
    Curr Opin Infect Dis; 2009 Oct; 22(5):455-63. PubMed ID: 19587589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
    Molefi M; Chofle AA; Molloy SF; Kalluvya S; Changalucha JM; Cainelli F; Leeme T; Lekwape N; Goldberg DW; Haverkamp M; Bisson GP; Perfect JR; Letang E; Fenner L; Meintjes G; Burton R; Makadzange T; Ndhlovu CE; Hope W; Harrison TS; Jarvis JN
    Trials; 2015 Jun; 16():276. PubMed ID: 26081985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.
    Day J; Imran D; Ganiem AR; Tjahjani N; Wahyuningsih R; Adawiyah R; Dance D; Mayxay M; Newton P; Phetsouvanh R; Rattanavong S; Chan AK; Heyderman R; van Oosterhout JJ; Chierakul W; Day N; Kamali A; Kibengo F; Ruzagira E; Gray A; Lalloo DG; Beardsley J; Binh TQ; Chau TT; Chau NV; Cuc NT; Farrar J; Hien TT; Van Kinh N; Merson L; Phuong L; Tho LT; Thuy PT; Thwaites G; Wertheim H; Wolbers M
    Trials; 2014 Nov; 15():441. PubMed ID: 25391338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
    Harrison TS; Lawrence DS; Mwandumba HC; Boulware DR; Hosseinipour MC; Lortholary O; Meintjes G; Mosepele M; Jarvis JN
    Clin Infect Dis; 2023 Mar; 76(5):944-949. PubMed ID: 36166405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.
    Bicanic T; Muzoora C; Brouwer AE; Meintjes G; Longley N; Taseera K; Rebe K; Loyse A; Jarvis J; Bekker LG; Wood R; Limmathurotsakul D; Chierakul W; Stepniewska K; White NJ; Jaffar S; Harrison TS
    Clin Infect Dis; 2009 Sep; 49(5):702-9. PubMed ID: 19613840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
    Kalinoski T; Malenfant J; Yim C; Jeng A
    Am J Trop Med Hyg; 2020 Aug; 103(2):713-718. PubMed ID: 32342852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.
    Boulware DR; Atukunda M; Kagimu E; Musubire AK; Akampurira A; Tugume L; Ssebambulidde K; Kasibante J; Nsangi L; Mugabi T; Gakuru J; Kimuda S; Kasozi D; Namombwe S; Turyasingura I; Rutakingirwa MK; Mpoza E; Kigozi E; Muzoora C; Ellis J; Skipper CP; Matkovits T; Williamson PR; Williams DA; Fieberg A; Hullsiek KH; Abassi M; Dai B; Meya DB
    Clin Infect Dis; 2023 Dec; 77(12):1659-1667. PubMed ID: 37606364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.
    Tenforde MW; Gertz AM; Lawrence DS; Wills NK; Guthrie BL; Farquhar C; Jarvis JN
    J Int AIDS Soc; 2020 Jan; 23(1):e25416. PubMed ID: 31957332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of cryptococcal meningitis in HIV-infected adults.
    McHale TC; Boulware DR; Kasibante J; Ssebambulidde K; Skipper CP; Abassi M
    Clin Microbiol Rev; 2023 Dec; 36(4):e0015622. PubMed ID: 38014977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcal meningitis.
    Tugume L; Ssebambulidde K; Kasibante J; Ellis J; Wake RM; Gakuru J; Lawrence DS; Abassi M; Rajasingham R; Meya DB; Boulware DR
    Nat Rev Dis Primers; 2023 Nov; 9(1):62. PubMed ID: 37945681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment.
    Zhao H; Lu Y; Li S; Qin J; Xu M; Ye H; Yang Z; Rao J; Chen G; Su F; Hu Z; Xu L
    Mycoses; 2024 Jan; 67(1):e13674. PubMed ID: 37986630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Cryptococcal Meningitis in a Late Presenter of HIV: A Rare Case Report and Review of Literature.
    Petrakis V; Angelopoulou CG; Psatha E; Grapsa A; Panopoulou M; Papazoglou D; Panagopoulos P
    Am J Case Rep; 2023 Dec; 24():e941714. PubMed ID: 38083828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
    Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-related neurodegeneration in the midbrain causes pulmonary dysfunction in murine cryptococcal IRIS.
    Dangarembizi R; Drummond R
    Trends Neurosci; 2023 Dec; 46(12):1003-1004. PubMed ID: 37806831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.